eyeforpharma Data Quality and Technology in Clinical Trials
In-Person Event
Apr 18 - 19, 2016
Philadelphia, Pennsylvania, USA
OVERVIEW
The conference will bring together all key stakeholders, so you can collaborate and identify solutions in order to;
- Maximize data quality: Enhance your trial rate of success with the perfect protocol design
- Become a data company: Work with pharma's leaders to design the analytics-driven organization of the future
- Harness the right analytics: Translate and adopt the hidden message behind your data
- Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring
- Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange
Why Attend?
- First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines.
- An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives
- Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques
- Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization
Price:
Silver Pass: USD1995
Gold Pass: USD2195
Speakers: Balazs Flink, Ashish Cowlagi, Scott Lowry, Mollie Shields Uehling, Christine Pierre, Immo Zadezensky, Alan Wright, Klaus Dugi, Barbara Tardiff, Anthony G. Johnson, Mark Wiener, Julian Jenkins, Robert DiCicco, Henrik Finnern, Joe Camardo
- Maximize data quality: Enhance your trial rate of success with the perfect protocol design
- Become a data company: Work with pharma's leaders to design the analytics-driven organization of the future
- Harness the right analytics: Translate and adopt the hidden message behind your data
- Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring
- Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange
Why Attend?
- First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines.
- An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives
- Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques
- Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization
Price:
Silver Pass: USD1995
Gold Pass: USD2195
Speakers: Balazs Flink, Ashish Cowlagi, Scott Lowry, Mollie Shields Uehling, Christine Pierre, Immo Zadezensky, Alan Wright, Klaus Dugi, Barbara Tardiff, Anthony G. Johnson, Mark Wiener, Julian Jenkins, Robert DiCicco, Henrik Finnern, Joe Camardo
KEY DATES
18 Apr, 2016
Event Start Date
19 Apr, 2016
Event End Date
SPECIALITIES
Alternative MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Le Meridien Philadelphia
Quick Links